iohexol has been researched along with Endocrine Gland Neoplasms in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Endocrine Gland Neoplasms: Tumors or cancer of the ENDOCRINE GLANDS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lefort, T | 1 |
Pilleul, F | 1 |
Mulé, S | 1 |
Bridal, SL | 1 |
Frouin, F | 1 |
Lombard-Bohas, C | 1 |
Walter, T | 1 |
Lucidarme, O | 1 |
Guibal, A | 1 |
1 other study available for iohexol and Endocrine Gland Neoplasms
Article | Year |
---|---|
Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation.
Topics: Adult; Aged; Blood Volume; Contrast Media; Endocrine Gland Neoplasms; Female; Humans; Iohexol; Liver | 2012 |